ag 30 has been researched along with alpha-cyanocinnamate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gazit, A; Gilon, C; Levitzki, A; Yaish, P | 1 |
| Bennis, K; Bourdier, G; Busserolles, J; Chapuy, E; Chatelain, FC; Devilliers, M; Ducki, S; Eschalier, A; Lesage, F; Lolignier, S; Prival, L; Rodrigues, N; Soussia, IB; Vivier, D | 1 |
2 other study(ies) available for ag 30 and alpha-cyanocinnamate
| Article | Year |
|---|---|
Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.
Topics: Benzylidene Compounds; Carcinoma, Squamous Cell; Cell Division; Cell Line; Epidermal Growth Factor; ErbB Receptors; Humans; Kinetics; Molecular Structure; Nitriles; Phosphorylation; Protein-Tyrosine Kinases; Structure-Activity Relationship | 1989 |
Development of the First Two-Pore Domain Potassium Channel TWIK-Related K
Topics: Analgesics; Animals; Potassium Channels, Tandem Pore Domain | 2017 |